Latest Tenders From Kazakh

Open House Drug Rebate Contracts Carbamazepine, Atc N03af01

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Fluticasone Vilanterol, Atc R03ak10 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Perindopril and Indapamide, Atc C09ba54 F. D. Z. 01.02.2023-31.01.2024 (Plus Extension Option 1X12 Months)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Ranolazine, Atc Code: C01eb18 for the Period from January 1St, 2023 to December 31St, 2024

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Ambroxol, Atc R05cb06 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Flupentixol (Exclusively Parenteral Dosage Form), Atc N05af01 for the Period February 1St, 2023 - January 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Methocarbamol (Only 1500 Mg), Atc M03ba03 for the Period February 1St, 2023 - January 31St, 2025

Open House Drug Rebate Contracts Trientine, Atc A16ax12

Open House Drug Rebate Contracts Buserelin, Atc L02ae01

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Secucinumab, Atc L04ac10 for the Period February 1St, 2023 - January 31St, 2025